NPR's Juana Summers talks to FDA Commissioner Martin Makary about the administration's decision to remove the black box warning label on hormone replacement therapy.
Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the Food and Drug Administration announced Monday.
Many doctors — and pharmaceutical companies — have called for removing or revising the label, which they say discourages prescriptions and scares off women who could benefit.
Many doctors — and pharmaceutical companies — have called for removing or revising the label, which they say discourages prescriptions and scares off women who could benefit.
Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the Food and Drug Administration announced Monday.
WASHINGTON (AP) — Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the Food and Drug Administration announced…
The Food and Drug Administration announced that hormone therapies for menopause will no longer need a black box warning about serious risks such as breast cancer, heart attack and stroke. NBC News’ Aria Bendix reports on why officials are…
EL PASO, Texas (KVIA) -- Warning labels on estrogen used in therapy for treating symptoms of menopause has discouraged many women from using it in the past. Today the Food and Drug Administration is asking companies to remove what is known…
The Food and Drug Administration is removing "black box" warnings on hormone therapy drugs used to treat menopause, Health and Human Services Secretary Robert F. Kennedy Jr. announced on Monday. CBS News' Shanelle Kaul has more.
Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the FDA announced.
The benefits of hormone replacement have been underappreciated, Dr. Marty Makary, the agency’s commissioner, said on Monday. Critics described evidence for the change as insufficient.
By MATTHEW PERRONE AP Health Writer WASHINGTON (AP) — Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the…
“Today, we are standing up for every woman who has symptoms of menopause and is looking to know her options and receive potentially life-changing treatment,” said Secretary Robert F. Kennedy.
WASHINGTON (AP) — Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the Food and Drug Administration announced…